The CathWorks FFRangio™ System brings you the definitive benefits of FFR guidance on a non-invasive platform, complete with accurate multi-vessel physiologic and anatomic insights to quickly optimize and confirm1 PCI decisions for more patients.
Improve patient outcomes with practical, intraprocedural multi-vessel FFR guidance.2
Eliminate risk and complexity of invasive FFR wires and hyperemic agents.
Quickly confirm resulting FFRangio after PCI.1
Plan procedures with advanced insights and decision tools.
Treat confidently with proven, highly accurate results.
Easy to use and faster than wire-based FFR.3
1. Diagnostic performance of FFRangio compared to FFR wires has not been established for lesions immediately after PCI.
2. FAME trial: Tonino PAL, et al. FFR-guided PCI improves outcomes compared to angiography-guided PCI. N Engl J Med. 2009 January 15;360(3):213-224. 10.1056/NEJMoa0807611
3. Omori H, et al. Angiogram based fractional flow reserve in patients with dual/triple vessel coronary artery disease. Int J Cardiol. 2019 May 15;283:17-22. 10.1016/j.ijcard.2019.01.072
Fill out the form to download the PDF and
learn about the clinical benefits of the
wire-free CathWorks FFRangio™ System.
Fill out the form to download the PDF and
learn about the clinical benefits of the
wire-free CathWorks FFRangio System.
Download our
informative PDF to
learn more about the
CathWorks
FFRangio™
System
© 2022 CathWorks. CathWorks and FFRangio are trademarks of CathWorks. MAR-000768 Rev 01